Azelastine Hydrochloride

Product NDC
51525-0294
11-digit product format
515250294
Labeler code
51525
Product ID
51525-0294_cfc4a967-4b48-4fc6-b0b7-6557945fe3f3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Azelastine Hydrochloride
Dosage form
SPRAY, METERED
Route
NASAL
Labeler
Wallace Pharmaceuticals Inc.
Application
NDA020114
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2010-07-01
Marketing end
0000-00-00
Substance
AZELASTINE HYDROCHLORIDE
Active strength
137 ug/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51525-0294-32020-07-22C16284748780-1ab0e2407-34d6-f274-e053-dbdaa90a64714b114460-7a1c-11df-8b19-0002a5d5c51b

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51525-0294-3ML - Milliliter51525-029465cda3ff-cb8d-4780-a846-35ba12b46e7112012-07-24

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
51525-0294-3515250294031 BOTTLE, SPRAY in 1 BOX (51525-0294-3) > 200 SPRAY, METERED in 1 BOTTLE, SPRAY2010-07-010000-00-00NoNoCurrent